1Glowacki Y, Diane M. Taking the "critical" out of critical cardiac care: what does the future hold for cardiac care units? Dimensions of Critical Care Nursing,2004,23(1):10-17.
2Seino Y, Ogawa A, Yamashita T, et al. Application of NT-proBNP and BNP measurements in cardiac care: a more discerning marker for the detection and evaluation of heart failure. Eur J Heart Fail,2004,6(3): 295-300.
3Stmgeun C,Gilja S. Evaluation of the B-type natriuretic peptide level in identifying patients with cardiovascular diseases in south korea.Point of Care: The Journal of Near-Patient Testing & Technology, .2005,4(1): 15-19.
4Jenny A, Doust B, Paul P, et al. A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. Arch Intern Med,2004,164(18): 1 978-1 984.
5Alan R, Tall MB. C-reactive protein Reassessed. The New Englandjournal of medicine,2004,350(14) : 1450-1452.
2Haverkate F.Thompson SG.Pyke SD.et al.Producation of C-reactive protein and rsk of coronary events in stable and unstable angina:european concerted action on thrombosis and disabilities angins pectoris study group[J].Lancet.1997.349:462-466.
3Morrow DA.Ridker PM.C-reactive protein.inflammation and coronary risk[J].Med Clin North Am 2000.84:149-161
5Ridker PM.Glynn RJ.Henneken CH.Careactive portein adds to the predictive value of total and HDL Cholesterol in determining risk of first my cardial infarction[J].Cricalation.1998.97:2007-2011
6Kiuzzo G.Biasueci LM.Gallimore JR.et al.The progmostic value of Creactive protein and serum amyloid a protein in severe unstable angina [J].N Engl J Med.1994.331:417-424
7Morrow DA.Riffai N.Antman EM.et al.C-reactive protein is a potent predictor of mortality idependently of and in combinaltion with troponin T in acute coronary syndromes:a TIMI 11 A subnstudy[J].J Am Coll Cardiol..1998.31:1460-1465.
